Literature DB >> 3244409

Effects of apomorphine in quantified electroencephalography in the frontal cortex: changes with dose and time.

A Shvaloff1, B Tesolin, C Sebban.   

Abstract

The purpose of this study was to investigate the role of four doses of apomorphine (0.01, 0.05, 0.25, 1 mg/kg s.c.) on the cortical activity by a quantified electroencephalography (EEG) method recently developed in our laboratory. The EEG-effects of apomorphine were changed significantly according to the dose and the time. When initial effects were considered an opposition in the apomorphine-induced variations between low (0.01 mg/kg) and higher doses were observed. In the time course with 0.01, 0.25 and 1 mg/kg SC, EEG variations changed the direction in 6-17 Hz and diminished in the other spectral components. Qualitatively, this tardive change with 0.01 mg/kg may show a feed-back response of the dopaminergic system to the initial low dose-induced depressant effects of apomorphine. On the other hand higher doses-induced tardive EEG pattern may show a possible changed balance in the stimulated D1 and D2 receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244409     DOI: 10.1016/0028-3908(88)90036-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission.

Authors:  C Sebban; X Q Zhang; B Tesolin-Decros; M J Millan; M Spedding
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil.

Authors:  C Sebban; B Tesolin-Decros; M J Millan; M Spedding
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors.

Authors:  W Kropf; K Kuschinsky; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

Review 4.  An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.

Authors:  Nicholas J Ashton; Abdul Hye; Anto P Rajkumar; Antoine Leuzy; Stuart Snowden; Marc Suárez-Calvet; Thomas K Karikari; Michael Schöll; Renaud La Joie; Gil D Rabinovici; Kina Höglund; Clive Ballard; Tibor Hortobágyi; Per Svenningsson; Kaj Blennow; Henrik Zetterberg; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2020-04-22       Impact factor: 42.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.